During the past 2 decades, research has shown multiple factors have led to an increase in elbow injuries and surgeries among youth, collegiate and professional overhead-throwing athletes.
Source: BioPharma Reporter
Generate Life Sciences is establishing a GMP facility in La Jolla, California that it says will enable end-to-end manufacturing of newborn stem cell biologics, bolstering supply and safeguarding clinical research.
A compassionate-use study has generated promising results for the potential treatment of muscular dystrophies using mesenchymal stem cells (MSCs) derived from Wharton’s jelly (WJ), a substance found in the umbilical cord. The study, led by doctors at Klara Medical Center (KMC), Czestochowa, Poland, and reported in STEM CELLS Translational Medicine, found that individuals treated using WJ-MSC exhibited significant improvement in several body muscles, with no serious side effects.
A study released in STEM CELLS Translational Medicine has confirmed the safety of a novel type of cellular therapy for knee pain caused by osteoarthritis. Conducted by a multi-institutional team of researchers in Japan who had developed the new therapy, the study was designed to confirm that their treatment – which involves transplanting the patient’s own mesenchymal stem cells (MSCs) into the affected knee – did not cause tumors.
Over the past five years, researchers have kept human embryos alive in culture longer than once thought possible and cultured stem cells into structures that model embryos and organs with unprecedented sophistication.
Source: MedCity News
Burn patients with the most serious wounds require an autograft: the harvesting of that person’s own healthy skin, which is then transplanted to the burn site. There is now a regenerative medicine alternative. The FDA has approved an engineered skin product that’s placed on the wound, serving as a scaffold for a patient’s skin cells to grow.
The U.S. Food and Drug Administration continues to facilitate the development and availability of innovative medical products, such as regenerative medicine therapies, that have the potential to treat or even cure diseases or conditions for which few effective treatment options exist.